Characterizing the Relationship Between Free Drug Samples and Prescription Patterns for Acne Vulgaris and Rosacea

Abstract

Importance Describing the relationship between the availability of free prescription drug samples and dermatologists’ prescribing patterns on a national scale can help inform policy guidelines on the use of free samples in a physician’s office. Objective To investigate the relationships between free drug samples and dermatologists’ local and national prescribing patterns and between the availability of free drug samples and prescription costs. Design, Setting, and Participants Cross-sectional study investigating prescribing practices for acne, a common dermatologic condition for which free samples are often available. The settings were, first, the offices of a nationally representative dermatologists from the National Disease and Therapeutic Index (an IMS Health Incorporated database) and, second, an academic medical center clinic without samples. Participants were ambulatory patients who received a prescription from a dermatologist for a primary initial diagnosis of either acne vulgaris or acne rosacea in 2010. Main Outcome Measures National trends in dermatologist prescribing patterns, the degree of correlation between the availability of free samples and the prescribing of brand-name medications, and the mean cost of acne medications prescribed per office visit nationally and at an academic medical center without samples. Results On a national level, the provision of samples with a prescription by dermatologists has been increasing over time, and this increase directly correlates with the use of the branded generic drugs promoted by these samples. Branded and branded generic drugs comprised most of the prescriptions written nationally (79%), while they represented only 17% at an academic medical center clinic without samples. Because of the increased use of branded and branded generic drugs, the national mean total retail cost of prescriptions at an office visit for acne was conservatively estimated to be 2 times higher (approximately $465 nationally vs $200 at an academic medical center without samples). Conclusions and relevance The benefits of free samples in dermatology must be weighed against potential negative impacts on prescribing behavior and prescription costs.

The US Food and Drug Administration’s drug safety recommendations and long-acting beta2-agonist dispensing pattern changes in adult asthma patients: 2003–2012

“…Third, physicians may provide patients with “doctors’ samples” (provided by pharmaceutical companies) in the US. Studies have shown that physicians who provide samples are more likely to prescribe the drug that may be more expensive and not the first-line therapy drugs 33,34. Claims data do not capture these “samples”, which may lead to an incomplete asthma drug dispensing.…”

Prescription patterns and costs of acne/rosacea medications in Medicare patients vary by prescriber specialty

“…While patients may be willing to pay more for a complete vs partial clearance of acne, 16 prescription rates of branded drugs are also subject to external influences, such as interactions with pharmaceutical sales representatives, 17 direct-to-consumer advertising, 18 and provision of free samples. 19 The former two influences may focus on tolerability and aesthetics of a vehicle without regard to the comparative effectiveness. Branded topical metronidazole was more than twice the total cost and five times the patient cost of generic versions, yet brand name usage was high across all specialties despite similar efficacy of branded gel vs cream and lotion vehicles.…”

Use of Prescription Drug Samples in the USA: A Descriptive Study with Considerations for Pharmacoepidemiology

“…In the USA, the pharmaceutical industry uses free samples as a marketing tool to familiarize prescribers with the drug. The impact of samples on prescriber behavior and cost to patients and the US healthcare system have been widely researched and discussed [2–10]. …”